These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death. Fidler SJ; Irish AB; Lim W; Ferrari P; Witt CS; Christiansen FT Transpl Immunol; 2013 Jun; 28(4):148-53. PubMed ID: 23665534 [TBL] [Abstract][Full Text] [Related]
11. Clinical significance of low pre-transplant donor specific antibodies (DSA) in living donor kidney recipients with negative complement-dependent cytotoxicity crossmatches (CDCXM), and negative flow cytometry crossmatches (FLXM) - A single-center experience. Olszowska-Zaremba N; Gozdowska J; Zagożdżon R Transpl Immunol; 2022 Oct; 74():101672. PubMed ID: 35868613 [TBL] [Abstract][Full Text] [Related]
12. C1q Binding Activity of De Novo Donor-specific HLA Antibodies in Renal Transplant Recipients With and Without Antibody-mediated Rejection. Yell M; Muth BL; Kaufman DB; Djamali A; Ellis TM Transplantation; 2015 Jun; 99(6):1151-5. PubMed ID: 25839705 [TBL] [Abstract][Full Text] [Related]
14. Effect of Preformed or De Novo Anti-HLA Antibodies on Function and Graft Survival in Kidney Transplant Recipients. de Sousa MV; Gonçalez AC; Zollner RL; Mazzali M Ann Transplant; 2018 Jul; 23():457-466. PubMed ID: 29976918 [TBL] [Abstract][Full Text] [Related]
15. Determining donor-specific antibody C1q-binding ability improves the prediction of antibody-mediated rejection in human leucocyte antigen-incompatible kidney transplantation. Malheiro J; Tafulo S; Dias L; Martins S; Fonseca I; Beirão I; Castro-Henriques A; Cabrita A Transpl Int; 2017 Apr; 30(4):347-359. PubMed ID: 27717025 [TBL] [Abstract][Full Text] [Related]
16. One-Year Outcomes of Living Related Kidney Transplant in Patients With Preformed HLA Donor-Specific Antibodies: A Single-Center Experience in Malaysia. Jalalonmuhali M; Ng KP; Mohd Shariff NH; Lee YW; Wong AH; Gan CC; Lim SK Transplant Proc; 2020; 52(6):1718-1722. PubMed ID: 32448671 [TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter? Crespo M; Torio A; Mas V; Redondo D; Pérez-Sáez MJ; Mir M; Faura A; Guerra R; Montes-Ares O; Checa MD; Pascual J Transpl Immunol; 2013 Dec; 29(1-4):28-33. PubMed ID: 23907088 [TBL] [Abstract][Full Text] [Related]
18. Pre-transplant donor specific antibody and its clinical significance in kidney transplantation. Thammanichanond D; Ingsathit A; Mongkolsuk T; Rattanasiri S; Kantachuvesiri S; Sakhonrat C; Leenanupan C; Worawichawongs S; Kitpoka P Asian Pac J Allergy Immunol; 2012 Mar; 30(1):48-54. PubMed ID: 22523907 [TBL] [Abstract][Full Text] [Related]
19. Low-MFI (median fluorescence intensity) pre-transplant DSA (donor specific antibodies) leading to anamnestic antibody mediated rejection in live-related donor kidney transplantation. Chauhan R; Tiwari AK; Aggarwal G; Gowri Suresh L; Kumar M; Bansal SB Transpl Immunol; 2023 Dec; 81():101931. PubMed ID: 37730185 [TBL] [Abstract][Full Text] [Related]